RE:RE:RE:RE:RE:RE:RE:Vulture Funds... Be my guest! After dumping ryplazim for a plate of lentils, being mired in tragic cash flow problems, and ceasing all research in once-promising areas and abandoning the associated intellectual property, this company, now run by a lawyer and under a nearly billion dollar lawsuit, is worthless as we speak. Under these circumstances, find me a single reason to believe it could be worth more than a few cents in a month or two. I repeat: ONE reason!